ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Saniona Ab

Saniona Ab (0RQJ)

33,35
0,00
( 0,00% )
Mis à jour : 01:00:00

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
33,35
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
33,35 Plage de 52 semaines 33,35
Cap du marché
Clôture Veille
33,35
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
2 009
Actions en circulation
64 127 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-22,32
Bénéfice par action (BPA)
-1,49
Chiffre d'affairess
16,84M
Bénéfice net
-95,81M

À propos de Saniona Ab

Secteur
Drugs And Proprietary-whsl
Industrie
Drugs And Proprietary-whsl
Site Web
Siège social
Glostrup, Dnk
Fondé
-
Saniona Ab est coté dans le secteur Drugs And Proprietary-whsl de la London Stock Exchange avec le ticker 0RQJ. Le dernier cours de clôture d'Saniona Ab était de SEK33,35. Au cours de la dernière année, les actions de Saniona Ab ont été négociées dans une fourchette de prix de SEK 33,35 à SEK 33,35.

Saniona Ab compte actuellement 64 127 000 actions en circulation. La capitalisation boursière d'Saniona Ab est de SEK2,14 milliard. Saniona Ab a un ratio cours/bénéfice (ratio PE) de -22.32.

0RQJ Dernières nouvelles

Saniona AB’s Nomination Committee for the Annual General Meeting 2023

Saniona AB’s Nomination Committee for the Annual General Meeting 2023 PRESS RELEASE November 25, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced the...

Saniona publishes its interim report for the third quarter of 2022

Saniona publishes its interim report for the third quarter of 2022   Three Months Ended September 30, 2022 (2021)Nine Months Ended September 30, 2022 (2021)Revenue was SEK 2.4 M (2.3...

Saniona’s anti-inflammatory and anti-fibrotic candidate SAN903 is ready for clinical studies

Saniona’s anti-inflammatory and anti-fibrotic candidate SAN903 is ready for clinical studies PRESS RELEASE November 3, 2022 SAN903 has finalized preclinical development and fulfilled other...

Saniona extends runway and amends loan agreement with Formue Nord

Saniona extends runway and amends loan agreement with Formue Nord PRESS RELEASE September 30, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that...

Saniona publishes its interim report for the second quarter of 2022

Saniona publishes its interim report for the second quarter of 2022 Three Months Ended June 30, 2022 (2021)Six Months Ended June 30, 2022 (2021)Revenue was SEK 3.0 M (1.9 M)Revenue was SEK...

Bulletin from the Saniona AB extraordinary general meeting on August 18, 2022

Bulletin from the Saniona AB extraordinary general meeting on August 18, 2022 PRESS RELEASE August 18, 2022 Today, on August 18, 2022, an extraordinary general meeting was held in Saniona...

Saniona progresses its Kv7 epilepsy program into Lead Optimization

Saniona progresses its Kv7 epilepsy program into Lead Optimization PRESS RELEASE August 16, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that it...

Saniona provides update on outstanding option programs

Saniona provides update on outstanding option programs PRESS RELEASE August 5, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that 6,450,734 options...

Notice of extraordinary general meeting in Saniona AB

Notice of extraordinary general meeting in Saniona AB PRESS RELEASE 15 July 2022 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the...

Saniona CEO Thomas Feldthus and board member Carl Johan Sundberg purchase Saniona shares in the open market

Saniona CEO Thomas Feldthus and board member Carl Johan Sundberg purchase Saniona shares in the open market PRESS RELEASE July 6, 2022 Saniona (OMX: SANION), a clinical stage...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10033.3533.3533.35412933.35DE
40033.3533.3533.35371633.35DE
120033.3533.3533.35200933.35DE
260033.3533.3533.35113333.35DE
520033.3533.3533.35173033.35DE
1560033.3533.3533.35282233.35DE
2600033.3533.3533.35255333.35DE

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SCGLSealand Capital Galaxy Limited
0,415p
(38,33%)
13,57M
SCESurface Transforms Plc
0,34p
(30,77%)
91M
BLUBlue Star Capital Plc
0,0225p
(28,57%)
73,32M
CRTACirata Plc
33,00p
(24,88%)
393,02k
COBRCobra Resources Plc
1,20p
(20,00%)
8,69M
UOGUnited Oil & Gas Plc
0,125p
(-34,21%)
115,26M
SYSSysgroup Plc
21,50p
(-24,56%)
360,65k
KEFIKefi Gold And Copper Plc
0,524p
(-19,63%)
247,82M
GNIPGenip Plc
15,50p
(-16,22%)
89,95k
GENLGenel Energy Plc
75,00p
(-14,87%)
1,59M
ORCPOracle Power Plc
0,0605p
(6,14%)
1,67B
KEFIKefi Gold And Copper Plc
0,524p
(-19,63%)
247,82M
NTVONativo Resources Plc
0,0023p
(-8,00%)
202,83M
CLONClontarf Energy Plc
0,0335p
(-10,67%)
117,55M
UOGUnited Oil & Gas Plc
0,125p
(-34,21%)
115,26M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock